Open access
Open access
Powered by Google Translator Translator

Cardiology

AHA Scientific Statement: Evolving Diagnosis and Management of Cardiac Amyloidosis

2 Jun, 2020 | 04:53h | UTC

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association – Circulation

Related: Cardiac Amyloidosis: Updates in Imaging (several reviews on the subject) AND AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management – JACC: CardioOncology AND Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis – Canadian Journal of Cardiology

 


Association of Dairy Consumption with Metabolic Syndrome, Hypertension and Diabetes in 147 812 Individuals from 21 Countries

2 Jun, 2020 | 04:52h | UTC

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries – BMJ Open Diabetes Research & Care

Commentary: Study shows dairy products are linked to lower risks of diabetes and high blood pressure – News Medical

 


Comprehensive Geriatric Assessment in the Management of Older Patients With Cardiovascular Disease

2 Jun, 2020 | 04:51h | UTC

Comprehensive Geriatric Assessment in the Management of Older Patients With Cardiovascular Disease – Mayo Clinic Proceedings

 


Study: Ramipril in High Risk Patients with COVID-19

1 Jun, 2020 | 03:53h | UTC

Ramipril in High Risk Patients with COVID-19 – Journal of the American College of Cardiology

 


[Abstract Only] Study: Primary Aldosteronism Common and Largely Unrecognized in Patients with Hypertension

1 Jun, 2020 | 03:41h | UTC

The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Aldosterone production is a common and unrecognized cause of high blood pressure – American College of Physicians

 


Study: No Evidence Blanket ‘Do-not-resuscitate’ Orders for COVID-19 Patients are Necessary

28 May, 2020 | 09:50h | UTC

No evidence blanket ‘do-not-resuscitate’ orders for COVID-19 patients are necessary – American Heart Association

Original Study: Survival After In-Hospital Cardiac Arrest In Critically Ill Patients: Implications For Covid-19 Outbreak? – Circulation: Cardiovascular Quality and Outcomes

 


Study: Early Cardiac MRI in Patients with Troponin-positive Acute Chest Pain and Non-obstructed Coronary Arteries

28 May, 2020 | 09:33h | UTC

Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries – Heart

 


Clinical Guidance: Advanced Pulmonary and Cardiac Support of COVID-19 Patients

27 May, 2020 | 02:27h | UTC

Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIOa Living Working Document – Circulation: Heart Failure

 


Randomized Trial: Antihypertensive Medication Reduction vs. Usual Care Among Older Adults Taking Multiple Antihypertensive Medications

27 May, 2020 | 02:16h | UTC

Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial – JAMA

Editorial: Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?

Commentary: Less is more? Deprescribing blood pressure lowering medications is safe in the short-term in older people with frailty and multiple long-term conditions – University of Oxford

 

Related Commentary on Twitter

 


[Abstract Only] Study: Estimating the Lifetime Benefits of a Multi-drug Regimen for Heart Failure

27 May, 2020 | 02:41h | UTC

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials – The Lancet (link to abstract – $ for full-text)

Commentary: Multi-drug regimen for heart failure could meaningfully extend patients’ lives – Brigham and Women’s Hospital

 

Related Commentary on Twitter

 


Review: COVID-19 and Cardiovascular Disease

26 May, 2020 | 10:05h | UTC

COVID-19 and Cardiovascular Disease – Circulation

Related Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology

 


Wide Complex Tachycardia Differentiation: A Reappraisal of the State‐of‐the‐Art

22 May, 2020 | 04:38h | UTC

Wide Complex Tachycardia Differentiation: A Reappraisal of the State‐of‐the‐Art – Journal of the American Heart Association

 


Meta-Analysis: Complete vs. Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction

22 May, 2020 | 04:36h | UTC

Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis – JAMA Cardiology (free for a limited period)

 


Characteristics and Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease

21 May, 2020 | 09:18h | UTC

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy – European Heart Journal

Commentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology

 


Cardiovascular Considerations in Treating Patients with COVID-19

21 May, 2020 | 09:16h | UTC

Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19) – Journal of Cardiovascular Pharmacology

Related: Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis – Current Problems in Cardiology AND Cardiology After COVID-19: Physicians Predict Lasting Change – TCTMD

See also: COVID-19: Updates for Cardiologists

 


Study Shows Lower Incidence of Hospitalization for Acute Myocardial Infarction After the Covid-19 Pandemic

20 May, 2020 | 09:54h | UTC

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction – New England Journal of Medicine

Related Study: Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy – New England Journal of Medicine

 


Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19

20 May, 2020 | 09:50h | UTC

ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis – Pharmacological Research

Related Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv

 


Meta-Analysis: Association of Blood Pressure Lowering with Incident Dementia or Cognitive Impairment

20 May, 2020 | 09:45h | UTC

Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis – JAMA (free for a limited period)

Commentary: Controlling blood pressure may reduce dementia risk by 7% – UPI

 


Covid-19 Case Series: Acute Heart Failure in Multisystem Inflammatory Syndrome in Children

19 May, 2020 | 04:37h | UTC

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic – Circulation

Related Case Report: Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19 – The Lancet Child & Adolescent Health

 

Related Commentary on Twitter

 


Systematic Review: Risks and Impact of ACE Inhibitors or ARBs on SARS-CoV-2 Infection in Adults

18 May, 2020 | 01:47h | UTC

Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review – Annals of Internal Medicine

Editorial: COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy – Annals of Internal Medicine

 


Study: Use of Renin–angiotensin–aldosterone System Inhibitors Does Not Increase the Risk of COVID-19 Requiring Admission to Hospital

18 May, 2020 | 01:45h | UTC

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study – The Lancet

Commentary: Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19 – The Lancet

 


Description of an Outbreak of Severe Kawasaki-like Disease at the Italian Epicenter of the SARS-CoV-2 Epidemic

15 May, 2020 | 03:53h | UTC

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study – The Lancet

Commentaries: Kawasaki-like disease: emerging complication during the COVID-19 pandemic – The Lancet AND Kawasaki-like COVID-19 complication found in Italian kids – CIDRAP AND What we know about the new Covid-19-linked illness in children – Vox AND Coronavirus: Children affected by rare Kawasaki-like disease – BBC

Related: Case Series: Hyperinflammatory Shock in Children During COVID-19 Pandemic

 


Cohort Study: Sugar‐Sweetened Beverage Intake Linked to Increased Cardiovascular Disease Risk

15 May, 2020 | 03:24h | UTC

Sugar‐Sweetened Beverage Intake and Cardiovascular Disease Risk in the California Teachers Study – Journal of the American Heart Association

Commentary: Drinking sugary drinks daily may be linked to higher risk of CVD in women – American Heart Association AND Gulping down 1 or more sugary drinks a day could put you at risk for cardiovascular disease – CNN

 


Meta-Analysis: Prognosis of Unrecognized Myocardial Infarction Determined by ECG or Cardiac MRI

12 May, 2020 | 03:10h | UTC

Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis – The BMJ

 


Comparison Approaches to Lipid Management: AHA/ACC vs. ESC/EAS Guidelines

12 May, 2020 | 03:07h | UTC

Comparison of Transatlantic Approaches to Lipid Management: The AHA/ACC/Multisociety Guidelines vs the ESC/EAS Guidelines – Mayo Clinic Proceedings

 


Stay Updated in Your Specialty

 

No spam, just news.